Anti-CTLA4 antibody-induced lupus nephritis.
Fadel
Fouad
F
El Karoui
Khalil
K
Knebelmann
Bertrand
B
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D015703:Antigens, CD / Q000276:immunology*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D060908:CTLA-4 Antigen; D006801:Humans; D000074324:Ipilimumab; D007668:Kidney / Q000473:pathology; D008181:Lupus Nephritis / Q000209:etiology*; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000970:Antineoplastic Agents; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab